• Source: Fosgonimeton

Fosgonimeton is an investigational new drug that is being evaluated to treat neurodegenerative diseases such as Alzheimer's and Parkinson's disease. It is a pro-drug of the active metabolite dihexa. Dihexa in turn binds to the hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met.




References

Kata Kunci Pencarian:

• Fosgonimeton
• Dihexa
• Insulin
• Dexamethasone
• Amitriptyline
• Testosterone
• Dehydroepiandrosterone
• Erythropoietin
• Anti-VEGF
• Filgrastim